|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ϵͳ�Ժ���Ǵ� |
|
IL-8 |
|
MCP-1 |
|
������ϸ������ |
| ��������������� | |
|
������ |
|
Ҷ���� |
|
��ѧ�� |
| PubMed | |
|
Article by ������ |
|
Article by Ҷ���� |
|
Article by ��ѧ�� |
������ϸ�����Ӽ�������ϵͳ�Ժ���Ǵ�
������1, Ҷ����1, ��ѧ��2
1. ����ҽ�ƴ�ѧ���в�������ͳ��ѧϵ, 230032;
2. ����ҽ�ƴ�ѧ��һ����ҽԺƤ�������Բ��о���
��������ѧ�ͷ�������ѧ�ķ�չ,Խ��Խ���������ϸ�����Ӽ������屻����.������,�Դ�������ϸ���������屻������ΪHIV��Ⱦ��Эͬ�����,������ϸ�������о���������㷺�Ĺ�ע.����������-8��������������-1�Լ���������������ϸ�����Ӽ���������ϵͳ�Ժ���Ǵ��Ĺ�ϵ,���������ϵͳ�Ժ���Ǵ������е�����.
1. ����ҽ�ƴ�ѧ���в�������ͳ��ѧϵ, 230032;
2. ����ҽ�ƴ�ѧ��һ����ҽԺƤ�������Բ��о���
1. ����ҽ�ƴ�ѧ���в�������ͳ��ѧϵ, 230032;
2. ����ҽ�ƴ�ѧ��һ����ҽԺƤ�������Բ��о���
[2](2):108-115.2.Wada T, Yokoyama H, Tomosugi N, et al. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int, 1994, 46(2):455-460.
[3] Tsai CY, Wu TH, Yu CL,et al. Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron,2000, 85(3):207-214.
[4] Holcombe RF, Baethge BA, Wolf RE,et al. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus.Lupus, 1994, 3(2):97-102.
[5] Hsieh SC, Tsai CY, Sun KH, et al. Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Clin Exp Rheumatol, 1994, 12(6):627-633.
[6] Sekikawa T, Kashihara N, Maruyama K, et al. Expression of interleukin-8 in human glomerulonephritis. Res Commun Mol Pathol Pharmacol, 1998, 99(2):217-224.
[7] Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.Lupus, 2000, 9(7):498-503.
[8] Sun KH, Yu CL, Tang SJ, et al. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-ibeta,IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology, 2000, 99(3):352-360.
[9] Noris M, Bernasconi S, Casiraghi F,et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest, 1995, 73(6):804-809.
[10] Zoja C, Coma D, Benedetti G, et al. Bindarit retards renal disease and prolonga survival in murine lupus autoimmune disease. Kidney Int, 1998, 53(3):726-734.
[11] Perez de Lema G, Maier H, Nieto E, et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol, 2001, 12(7):1369-1382.
[12] Rovin BH, Lu L, Marsh CB. Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking;role of IL-1 beta. J Leukoc Biol, 2001, 69(3):435-439.
[13] Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun, 1999, 259(2):344-348.
[14] Szalai C, Kozma GT, Nagy A, et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol, 2001, 108(3):375-381.
[15] Szalai C, Duba J, Prohaszka Z, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease(CAD). Coincidence of elevated Lp(a) and MCP-1 2518 G/G genotype in CAD patients. Atherosclerosis, 2001,158(1):233-239.
[16] Kaneko H, Ogasawara H, Naito T, et al. Circulating levels of betachemokines in systemic lupus erythematosus. J Rheumatol, 1999, 26(3):568-573.
[17] Narumi S, Takeuchi T, Kobayashi Y, et al. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus. Cytokine, 2000, 12(10):1561-1565.
[18] Ishikawa S, Sato T, Abe M,et al. Aberrant high expression of B lymphocyte chemokine(BLC/CXCL13) by C11b+ CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med, 2001, 193(12):1393-1402.
[19] Hase K, Tani K, Shimizu T,et al. Increased CCR4 expression in active systemic lupus erythematosus. J Leukoc Biol, 2001,70(5):749-755.
[20] Gomez-Reino JJ, Pablos JL, Carreira PE, et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Artbritis Rheum, 1999, 42(5):989-992.
[21] Mantovani A. The chemokine system;redundancy for robust outputs.Immunol Today, 1999, 20(6):254-257.